STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

DVAX DYNAVAX TECHNOLOGIES CORPORATION StockScouter® Report

4

StockScouter® Score

DYNAVAX TECHNOLOGIES CORPORATION, a small cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
  • Short-term relative price momentum exhibits meaningful strength. Postive

 

Concerns

  • One or more analysts has significantly decreased quarterly earnings estimates for DVAX. Negative
  • The multi-period measure of relative price change and consistency is well below average. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.

Expected Risk/Return

Progress: 80% done.
Progress: 80% done.
Low
High

Core Model Grades

B
C
C
F

Previous Ratings

1
4
1